default author photo

Hiroyuki Yasojima

National Hospital Organization (NHO) - Department of Surgery

SCHOLARLY PAPERS

1

DOWNLOADS

102

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Genomic and Transcriptomic Profiling of Triple Negative Breast Cancer Patients Treated with Paclitaxel and Eribulin Containing Neoadjuvant Chemotherapy and Response Prediction

Number of pages: 48 Posted: 17 Mar 2023
Kyoto University - Department of Next-generation Clinical Genomic Medicine, Kyoto University - Department of Breast Surgery, Nagoya University - Department of Breast and Endocrine Surgery, Kyoto University - Department of Breast Surgery, Kyoto University - Center for Genomic Medicine, Kyoto University - Department of Breast Surgery, Kyoto University - Department of Breast Surgery, Kyoto University - Department of Breast Surgery, Kobe City Medical Center General Hospital - Department of Breast Surgery, Hiroshima University - Department of Breast Surgery, University of Tsukuba - Breast and Endocrine Surgery, Chiba Cancer Center - Department of Breast Surgery, Kumamoto University - Department of Breast and Endocrine Surgery, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, National Hospital Organization (NHO) - Department of Surgery, Saitama Medical University International Medical Center (SIMC) - Breast Oncology Service, Kyoto University - Department of Biomedical Statistics and Bioinformatics, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Diagnostic Pathology, Kyoto University Hospital, Kyoto University - Center for Genomic Medicine, Kyoto University - Department of Pathology and Tumor Biology and Kyoto University - Department of Breast Surgery
Downloads 102 (679,608)

Abstract:

Loading...

Triple negative breast cancer, HRD, microtubule inhibitors, eribulin, response, resistance